Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

The role of fat topology in the risk of disease

International Journal of Obesity volume 32, pages S83–S92 (2008)Cite this article

Abstract

Clustering of multiple risk factors such as impaired glucose metabolism, lipid disorders and hypertension has been shown to be the major background of atherosclerotic diseases, and disease entities such as the metabolic syndrome represent a highly atherogenic state. Although these common risks may generally co-exist by accident in one individual, clustering of multiple risk factors in the metabolic syndrome does not occur by accident, and there should be a key player for the syndrome. In 1983, we reported the method for fat analysis using computed tomography scan, which enables us to analyze intra-abdominal visceral adiposity as well as subcutaneous fat. Visceral fat accumulation has been shown to cause impaired glucose metabolism, lipid disorders, and hypertension, and therefore it is considered to be a key player in the metabolic syndrome. To clarify the mechanism by which visceral fat accumulation causes a variety of metabolic and vascular diseases, we studied the molecular characteristics of adipose tissue and adipocytes by investigating expressed genes in visceral and subcutaneous adipocytes and revealed that adipocytes, especially visceral adipocytes, secrete a variety of bioactive substances, the so-called adipocytokines. We showed that visceral fat accumulation causes abnormalities in adipocytokine secretion, such as hypersecretion of plasminogen activator inhibitor 1, which is related to thrombogenic vascular diseases. More importantly, we discovered an important benign adipocytokine named adiponectin, which protects against the development of diabetes mellitus, hypertension, inflammation, and atherosclerotic vascular diseases. Plasma levels of adiponectin decreased in individuals with visceral fat accumulation, and hypoadiponectinemia caused by visceral fat accumulation might be one of the major causes of metabolic syndrome.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9
Figure 10
Figure 11
Figure 12

Similar content being viewed by others

References

  1. Vague J . La differentiation sexuelle, facteur determinant des formes de l’obesite. Press Med 1947; 55: 339–340.

    CAS  PubMed  Google Scholar 

  2. Björntorp P . Regional patterns of fat distribution. Ann Intern Med 1985; 103: 994–995.

    Article  Google Scholar 

  3. Kissebah AH, Vydelingum N, Murray R, Evans DJ, Harz AJ, Kalkhoff RK et al. Relation of body fat distribution to metabolic complications of obesity. J Clin Endocrinol Metab 1982; 54: 254–260.

    Article  CAS  Google Scholar 

  4. Tokunaga K, Matsuzawa Y, Ishikawa K, Tarui S . Novel technique for the determination of body fat by computed tomography. Int J Obes 1983; 7: 437–445.

    CAS  PubMed  Google Scholar 

  5. Matsuzawa Y, Fujioka S, Tokunaga K, Tarui S . A novel classification: visceral fat obesity and subcutaneous obesity. In: Berry EM, Blondheim SH (eds). Recent Advances in Obesity Research V. John Libbey: London, 1987, pp 92–96.

    Google Scholar 

  6. Fujioka S, Matsuzawa Y, Tokunaga K, Tarui . Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism. Metabolism 1987; 3: 54–59.

    Article  Google Scholar 

  7. Kanai H, Matsuzawa Y, Kotani K, Keno Y, Kobatake T, Nagai Y et al. Close correlation of intraabdominal fat accumulation to hypertension in obese women. Hypertension 1990; 16: 484–490.

    Article  CAS  Google Scholar 

  8. Depres JP, Nadeau A, Tremblay A . Role of deep abdominal fat in the association between regional adipose tissue distribution and glucose tolerance in obese women. Diabetes 1989; 38: 304–309.

    Article  Google Scholar 

  9. Matsuzawa Y . Pathophysiology and molecular mechanism of visceral fat syndrome: the Japanese case. Diabetes/Metab Rev 1996; 13: 3–13.

    Article  Google Scholar 

  10. Nakamura T, Tokunaga K, Shimomura I, Nishida M, Yoshida S, Kotani K et al. Contribution of visceral fat accumulation to the development of coronary artery disease in non-obese men. Atherosclerosis 1994; 107: 239–246.

    Article  CAS  Google Scholar 

  11. Reaven GM . Role of insulin resistance in human disease. Diabetes 1988; 37: 1595–1607.

    Article  CAS  Google Scholar 

  12. Kaplan NM . The deadly quartet. Arch Intern Med 1989; 149: 1514–1520.

    Article  CAS  Google Scholar 

  13. Alberti KG, Zimmet P, Shaw J . Metabolic syndrome—a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diab Med 2006; 23: 1385–1386.

    Article  Google Scholar 

  14. Kotani K, Tokunaga K, Fujioka S, Kobatake T, Keno Y, Yoshida S et al. Sexual dimorphism of age-related changes in whole body fat distribution in the obese. Int J Obes 1994; 18: 207–212.

    CAS  Google Scholar 

  15. Keno Y, Matsuzawa Y, Tokunaga K, Fujioka S, Kawamoto T, Kobatake T et al. High sucrose diet increases visceral fat accumulation in VMH-lesioned obese rats. Int J Obes 1991; 15: 205–211.

    CAS  PubMed  Google Scholar 

  16. Matsuzawa Y, Fujioka S, Tokunaga K, Tarui S . Classification of obesity with respect to morbidity. Proc Soc Exp Biol Med 1992; 200: 197–201.

    Article  CAS  Google Scholar 

  17. Clemens K, Vaisse C, Manning BSJ, Basdevant A, Guy-Grand B, Ruiz J et al. Genetic variation in the β3-adrenergic receptor and increased capacity to gain weight in patients with morbid obesity. N Engl J Med 1995; 333: 352–354.

    Article  Google Scholar 

  18. Kuriyama H, Yamashita S, Shimomura I, Funahashi T, Matsuzawa Y . Enhanced expression of hepatic acylCoA synthetase and microsomal triglyceride transfer protein mRNAs in the obese and hypertriglyceridemic rats with visceral fat accumulations. Hepatology 1998; 2: 557–562.

    Article  Google Scholar 

  19. Maeda K, Okubo K, Shimomura I, Mizuno K, Funahashi T, Matsuzawa Y et al. Analysis of expression profile of genes in the human adipose tissue. Gene 1997; 190: 227–235.

    Article  CAS  Google Scholar 

  20. Kishida K, Kuriyama H, Funahashi T, Shimomura I, Kihara S, Ouchi N et al. Aquaporin adipose, a putative glycerol channel in adipocytes. J Biol Chem 2000; 275: 20896–20902.

    Article  CAS  Google Scholar 

  21. Kishida K, Shimomura I, Kondo H, Kuriyama H, Makino Y, Nishizawa H et al. Genomic structure and insulin-mediated repression of the aquaporin adipose, adipose-specific glycerol channel. J Biol Chem 2001; 276: 36251–36260.

    Article  CAS  Google Scholar 

  22. Matsuzawa Y . Therapy insight: adipocytokines in metabolic syndrome and related cardiovascular disease. Nat Clin Pract Cardiovasc Med 2006; 3: 35–42.

    Article  CAS  Google Scholar 

  23. Shimomura I, Funahashi T, Takahashi M, Maeda K, Kotani K, Nakamura T et al. Enhanced expression of PAI-1 in visceral fat: possible contribution to vascular disease in obesity. Nat Med 1997; 2: 1–5.

    Google Scholar 

  24. Maeda K, Okubo K, Shimomura I, Funahashi T, Matsuzawa Y, Matsubaa K . cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (Adipose most Abundant Gene Transcript 1). Biochem Biophys Res Commun 1996; 22: 286–289.

    Article  Google Scholar 

  25. Matsuzawa Y . Adiponectin: identification, physiology and clinical relevance in metabolic and vascular disease. Atherosclerosis 2005; 6 (Suppl): 7–14.

    Article  CAS  Google Scholar 

  26. Maeda N, Shimomura I, Kishida K, Nishizawa H, Matsuda M, Nagaretani H et al. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med 2002; 8: 731–737.

    Article  CAS  Google Scholar 

  27. Lindsay RS, Funahashi T, Hanson RL, Matsuzawa Y, Tanaka S, Tataranni PA et al. Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet 2002; 360: 57–58.

    Article  CAS  Google Scholar 

  28. Zoccali C, Mallamaci F, Tripepi G, Benedetto FA, Cutrupi S, Parlongo S et al. Adiponectin, metabolic risk factors, and cardiovascular disease. J Am Soc Nephrol 2002; 13: 134–141.

    Article  CAS  Google Scholar 

  29. Kumada M, Kihara, Sumitsuji S, Kawamoto T, Matsumoto, Ouchi N et al. Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol 2002; 23: 85–89.

    Article  Google Scholar 

  30. Kishida K, Nagaretani H, Kondo H, Kobayashi H, Tanaka S, Maeda N et al. Disturbed secretion of adiponectin of mutant adiponectin associated with the metabolic syndrome. Biochem Biophys Res Commun 2003; 306: 286–292.

    Article  CAS  Google Scholar 

  31. Kamada Y, Matsumoto H, Tamura S, Fukushima J, Kiso S, Fukui K et al. Hypoadiponectinemia accelerates hepatic tumor formation in a nonalcoholic steatohepatitis mouse model. J Hepatol 2007; 47: 556–564.

    Article  CAS  Google Scholar 

  32. Yokota T, Oritani K, Takahashi I, Ishikawa J, Matsuyama A, Ouchi N et al. Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of monocyte progenitors and the functions of macrophages. Blood 1999; 96: 1727–1732.

    Google Scholar 

  33. Okamoto Y, Kihara S, Ouchi N, Nishida M, Arita Y, Kumada M et al. Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice. Circulation 2002; 26: 2767–2770.

    Article  Google Scholar 

  34. Ouchi N, Kihara S, Arita Y, Okamoto Y, Maeda K, Kuriyama H et al. Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway. Circulation 2000; 102: 1296–1301.

    Article  CAS  Google Scholar 

  35. Ouchi N, Kihara S, Funahashi T, Nakamura T, Nishida M, Kumada M et al. Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue. Circulation 2003; 107: 671–674.

    Article  CAS  Google Scholar 

  36. Matsuzawa Y . Adiponectin and inflammation. In: Fantuzzi G, Mazzone T (eds). Nutrition and Health. Adipose and Adipokines in Health and Disease. Human Press Inc.: Totowa, NJ, 2007, pp 111–117.

    Google Scholar 

  37. Kumada M, Kihara S, Ouchi N, Kobayashi H, Okamoto Y, Ohashi K et al. Adiponectin specifically increased tissue metalloproteinase 1 through interleukin expression in human macrophages. Circulation 2004; 109: 2046–2049.

    Article  CAS  Google Scholar 

  38. Okamoto Y, Arita Y, Nishida M, Muraguchi M, Ouchi N, Takahashi M et al. An adipocyte-derived protein, adiponectin, adheres to injured vascular walls. Horm Metab Res 2000; 32: 47–50.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Sumitomo Hospital, Professor Emeritus Osaka University, Kita-Ku, Osaka, Japan

    Y Matsuzawa

Authors
  1. Y Matsuzawa
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Y Matsuzawa.

Additional information

Conflict of interest

The author has declared no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Matsuzawa, Y. The role of fat topology in the risk of disease. Int J Obes 32 (Suppl 7), S83–S92 (2008). https://doi.org/10.1038/ijo.2008.243

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ijo.2008.243

Keywords

This article is cited by

Search

Advanced search

Quick links